{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:17Z","timestamp":1787889977329,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cmi.2020.06.020","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T11:29:05Z","timestamp":1593257345000},"page":"1171-1177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Corticosteroid administration for viral pneumonia: COVID-19 and beyond"],"prefix":"10.1016","volume":"26","author":[{"given":"J.-W.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-G.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.06.020_bib1","series-title":"Coronavirus disease (COVID-19) outbreak situation","year":"2020"},{"key":"10.1016\/j.cmi.2020.06.020_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00134-020-05943-5","article-title":"Critical care management of adults with community-acquired severe respiratory viral infection","volume":"46","author":"Arabi","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib5","doi-asserted-by":"crossref","first-page":"107428","DOI":"10.1016\/j.pharmthera.2019.107428","article-title":"Use of glucocorticoids in the critical care setting: science and clinical evidence","volume":"206","author":"Chan","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cmi.2020.06.020_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.06.020_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome","volume":"183","author":"Brun-Buisson","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00134-010-2078-z","article-title":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) influenza A infection","volume":"37","author":"Martin-Loeches","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","article-title":"Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores","volume":"183","author":"Kim","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/cid\/cir398","article-title":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection","volume":"53","author":"Han","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.06.020_bib13","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1183\/09031936.00169714","article-title":"Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients","volume":"45","author":"Lee","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2020.06.020_bib14","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/CCM.0000000000001616","article-title":"Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia","volume":"44","author":"Cao","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib15","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","article-title":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study","volume":"44","author":"Moreno","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.129.6.1441","article-title":"Treatment of severe acute respiratory syndrome with glucosteroids","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2020.06.020_bib17","first-page":"98","article-title":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study","volume":"51","author":"Auyeung","year":"2005","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.06.020_bib18","first-page":"28","article-title":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","volume":"54","author":"Yam","year":"2007","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.06.020_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2020.06.020_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia","volume":"39","author":"Shang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jiu645","article-title":"Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis","volume":"212","author":"Rodrigo","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.06.020_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cmi.2015.06.022","article-title":"Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.06.020_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13054-015-0764-5","article-title":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis","volume":"19","author":"Zhang","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2020.06.020_bib26","first-page":"CD010406","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"3","author":"Rodrigo","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2020.06.020_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2020.06.020_bib28","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis","volume":"48","author":"Lansbury","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib29","first-page":"1","article-title":"Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2020.06.020_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/cid\/ciy874","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.06.020_bib31","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.200306-766OC","article-title":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome","volume":"168","author":"Ho","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.2003.014076","article-title":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak","volume":"59","author":"Sung","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2020.06.020_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM200307313490519","article-title":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids","volume":"349","author":"Wang","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib34","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00198-016-3824-z","article-title":"Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis","volume":"28","author":"Zhao","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cmi.2020.06.020_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.06.020_bib37","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","volume":"368","author":"Xu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2020.06.020_bib38","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib39","first-page":"388","article-title":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China","volume":"80","author":"Yang","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2020.06.020_bib40","article-title":"Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study","author":"Wu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.06.020_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41392-020-0127-9","article-title":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cmi.2020.06.020_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-020-0158-2","article-title":"A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cmi.2020.06.020_bib44","doi-asserted-by":"crossref","first-page":"104363","DOI":"10.1016\/j.jcv.2020.104363","article-title":"Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China","volume":"127","author":"Li","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2020.06.020_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa242","article-title":"Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) out of Wuhan","author":"Lian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.06.020_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.06.020_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cmi.2020.06.020_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2020.06.020_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.cmi.2020.06.020_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2020.06.020_bib52","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus","volume":"382","author":"Perlman","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.06.020_bib54","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3389\/fmicb.2019.02752","article-title":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score","volume":"10","author":"Guo","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2020.06.020_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2020.06.020_bib57","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T\u00a0cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J\u00a0Virol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20303645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20303645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:58Z","timestamp":1761117958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20303645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1198743X20303645"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.06.020","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroid administration for viral pneumonia: COVID-19 and beyond","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}